NMRA icon

Neumora Therapeutics
NMRA

Overview Fund Trends Analyst Outlook Journalist POV

38 hedge funds and large institutions have $512M invested in Neumora Therapeutics in 2023 Q3 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$108M
2
+$79.4M
3
+$62.9M
4
WT
Wellcome Trust
United Kingdom
+$46.7M
5
AG
Artal Group
Luxembourg
+$39.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$108M
2
$79.4M
3
$62.9M
4
$46.7M
5
$39.5M
6
$29.7M
7
$29.2M
8
$25.4M
9
$24M
10
$21.2M
11
$12.9M
12
$8.3M
13
$3.88M
14
$3.62M
15
$2.82M
16
$2.12M
17
$2.12M
18
$1.72M
19
$1.3M
20
$1.04M
21
$825K
22
$706K
23
$706K
24
$672K
25
$617K
1
2